Select Page

Our Executive Team

A world class management team backed up with a dedicated medical team uniquely positions BioPharma to progress your drug development programme

RENZO DICARLO
Chief Executive Officer
Renzo DiCarlo is Chief Executive Officer (CEO) and Member of the Board of Directors at BioPharma Services. Since 2011, Renzo has been integral in expanding BioPharma’s clinical footprint into the USA and fortifying their Bioanalytical Lab operations to meet the growing volume demand. Prior to his joining BioPharma, Renzo held senior executive management posts in the Life Sciences sector with extensive international experience working in North America, Europe, Asia and Africa. He has inspired teams to innovate and deliver first-in-world NDA approved therapeutic drugs and medical devices in a variety of cultures and languages.
View Details
ANNA TAYLOR
Executive VP of Business Development
Anna Taylor is the Executive Vice President of Business Development at BioPharma Services. Having been a member of the BioPharma team since 2007, Anna brings together her extensive knowledge of clinical trial research and strong acumen for client service and relationship management to successfully lead BioPharma’s Global Business Development unit. With over 15 years of experience in the Contract Research Organization industry, Anna has held management positions in both Business Development and Project management, assisting pharmaceutical clients with their Phase I, Bioequivalence and Bioanalytical needs.
View Details
DR. JOHN OLDENHOF
Chief Scientific Officer
Dr. John Oldenhof is the Chief Scientific Officer at BioPharma Services. John joined the BioPharma team in 2018 and brings with him 18 years of senior management experience in Phase I clinical pharmacology, product development, biostatistics, data management and regulatory and scientific affairs. His published work and experience includes the development of novel methodologies, innovative study designs and direct collaboration with the US Food and Drug Administration (FDA) to advance human abuse potential studies and pharmacometrics analyses.

Over his tenure in Clinical Pharmacology, Dr. Oldenhof has provided scientific and regulatory guidance to biotech and pharmaceutical sponsors on over 300 clinical pharmacology studies including FIM, SAD/MAD, DDI and TQT studies to support pre-IND, NDA, ANDA and product launches.

Dr. Oldenhof holds an Adjunct Lecturer position in the Department of Pharmacology & Toxicology at the University of Toronto and is a parent member of the Genetic Epilepsy STXBP1 Disorder Scientific Advisory Board.
View Details
LOUIS CO
VP of Global Clinical Operations
Louis Co is the Vice President of Global Clinical Operations at BioPharma Services. Louis first joined BioPharma in 2009 to oversee day-to-day clinical operations. During his tenure, Louis has focused on optimizing operational effectiveness, executed effective change management and positioned BioPharma for growth and expansion. With 20 years of clinical research experience and 500+ clinical trials executed, Louis is now responsible for global operations of both BioPharma’s clinical units in Toronto, Canada and St. Louis, USA. Louis attended McMaster University and George Brown College and is a Registered Nurse with the College of Nurses of Ontario.
View Details
DR. NICKI HUGHES
VP of Lab Operations
Dr. Nicki Hughes is the Vice President of Bioanalytical Operations at BioPharma Services. Nicki joined the BioPharma team in 2016 after facilitating an acquisition that would have her former team at Bioanalytical Laboratory Services (BLS), a division of LifeLabs, and founded by Nicki in 2013, merge with BioPharma’s existing bioanalytical operations. This acquisition reinforced BioPharma’s footprint in delivering best in class bioanalytical services, making it a global leader in clinical research. Nicki has over 20 years of research experience and proven leadership skills. Her mandate starts with R&D, to develop robust and reliable methods to drive efficiency, expedite analysis and deliver accurate and time-critical results.
View Details
JO ANN DI SENSI
VP of Global Quality Assurance and Privacy Officer
Jo Ann Di Sensi is the Vice President of Global Quality Assurance and Privacy Officer at BioPharma Services. Jo Ann is an accomplished QA professional with over 24 years of Quality Assurance/Quality Systems and Compliance experience in the Clinical Research, Analytical and Cannabis Industries.   As Privacy Officer, Jo Ann ensures compliance related to privacy, security and confidentiality with application legislation for the protection of personal information. Within the Clinical Research field, she provided leadership and management of over 1000 Phase I and bioequivalence/bioavailability clinical trials.

Jo Ann has been a member of the BioPharma team since March 2020 and is largely responsible for implementing the quality standards and systems that govern BioPharma’s global operations. In addition to having extensive knowledge of the International Standards of GCP and GLP, Jo Ann has successfully led numerous regulatory inspections including the US FDA, UK MHRA, ANVISA, SCC, CAEAL, CFIA, EMA, Menviq and Health Canada, as well as numerous audits by pharmaceutical and biotech companies.
View Details
BRIAN LUKIAN
Chief Financial Officer
Brian Lukian is the Chief Financial Officer at BioPharma Services. With over 25 years of experience in financial, strategic and business leadership, Brian joined BioPharma in 2016 with a proven track record of increasing company productivity including several start-up organizations. Previous to his joining, Brian held senior executive financial roles managing revenues of $35M to $200M, annually. Brian’s primary strength and expertise is centered around financial strategy, acquisitions and equity negotiations. Brian was educated at Concordia University and earned his accreditations from McGill University and Ernst & Young.
View Details
SIMON CORMAN
VP of Corporate Strategy
As a 20 year veteran of the clinical research industry, Simon has remained at the forefront of leveraging new technologies and business models to accelerate organizational growth in the highly regulated clinical trials industry. With a focus on quality, scalability, and innovation, he has held a variety of leadership roles including leading of one of North America’s largest Central Ethics Boards/Central IRBs as well as being a key member in creating one of the world’s largest clinical research site networks. He launched one of the industry’s first cloud based e-clinical systems and has been involved with the digital transformation of several organizations, leveraging analytics to help drive data driven decision making, including working on decentralized trials and big data AI initiatives. He has also been an active participant in the consolidation of the industry through mergers and acquisitions and has provided strategic direction for some of the industry’s largest investment firms. With a keen eye for future trends, Simon is able to provide innovative solutions and thoughtful leadership. He joined BioPharma Services as VP of Corporate Strategy in 2020.
View Details

Our Medical Team

DR. ESMAT DESSOUKI
MD, Chief Medical Officer & Principal Investigator
Dr. Esmat Dessouki is the Chief Medical Officer and Principal Investigator at BioPharma Services. Having completed his residencies in orthopedic medicine in Egypt (1987) and Saskatchewan, Dr. Dessouki went on to become an Orthopedic Surgeon and continues to practice at Lakeridge Health Corporation (formerly Oshawa General Hospital). Along with two fellow physicians, Dr. Dessouki founded BioPharma Services in 2006 becoming first the Chief Executive Officer and then Medical Director. Beginning in 2013, Dr. Dessouki has served as Sub-Investigator or Principal Investigator for over 100 clinical trials for a wide range of therapeutic areas.
View Details
DR. FATHI ABUZGAYA
MD, Principal Investigator
Dr. Abuzgaya gained his medical degree in Libya (1981) and went on to complete his residency at the University of Toronto specializing in orthopedic surgery. He was Chief of Surgery and Chief of Staff at Rouge Valley Health System (previously Ajax and Pickering General Hospital) and continues to practice as an Orthopedic Surgeon with Rouge Valley. Beginning in 2006, Dr. Abuzgaya has served as Sub-Investigator or Principal Investigator for over 100 clinical trials for a wide range of therapeutic areas.
View Details
DR. ISABELLA SZETO
MD, CCFP, FCFP, CPI & Principal Investigator

With over 15 years of experience in Phase I and Human Abuse Potential studies, Dr. Szeto has been Principal or Sub-investigator for 150+ studies. Dr. Szeto gained her medical degree from the University of Western Ontario (1997) and has been an Emergency physician in the Toronto Area since 2003. Dr. Szeto has also practised family medicine in a remote First Nation community in Northern Ontario.
View Details
DR. ARTAN MARKOLLARI
MD, Principal Investigator
With over 21 years of experience in Family Medicine, Dr. Markollari joined the clinical research community more than five years ago serving as an Investigator for Phase I clinical trials and Bioequivalence studies in the St. Louis area. He joined BioPharma Services in 2020 and serves as the Principal Investigator for our US centre.
View Details
What are early phase clinical trials?

Clinical Trials are divided into 4 phases.  Phase 1 and 2 trials constitute early phase trials, Phase 3 and 4 research studies are late-phase trials.

The primary objective of Phase 1 studies is to determine the correct drug dosage by evaluating drug safety and determining if there are any side effects.  Phase 1 trials are conducted in healthy volunteers.

Phase 2 studies also study the safety of a drug but focus on evaluating its effectiveness. These studies can be conducted in healthy volunteers or in individuals who have a certain disease or condition.

What is a clinical trial?

A Clinical trial is a process which is performed to determine whether an investigational drug, device or therapy is safe and effective.   In early phase research (i.e. Phases 1 and 2), the safety and effectiveness of the drug will be evaluated in healthy volunteers.

What is an investigational drug?

An investigational drug can also be called an experimental drug and is being studied to see if your disease or medical condition improves while taking it. Scientists are trying to prove in clinical trials:

  • If the drug is safe and effective.
  • How the drug might be used in that disease.
  • How much of the drug is needed.
  • Information about the potential benefits and risks of taking the drug.
Why do you need to take blood draws and how many blood draws will be required?

In order to evaluate the drug profile, we need to understand its pharmacokinetics. This is essentially how the body reacts to a drug after its administration through the mechanisms of absorption, distribution, as well as the metabolic changes. Therefore, blood draws are collected at various time points to better understand this mechanism. Each study requires a specific number of blood draws and total blood volume. These values will be provided to you and clearly stipulated in the informed consent form (ICF). The amount of blood that will be taken is outlined in the ICF.

Should I expect to experience any side-effects while doing studies?

As every study is testing an investigational product, there may be side effects. You will be provided with a list of side effects that have been reported in previous trials (if any), so you can make an informed decision whether or not to participate in the trial. During the trial you will be required to immediately inform clinic study staff of any adverse effects that you are experiencing. These side effects usually resolve upon discontinuation of the study drug.

Will I be compensated for doing a clinical study?

Volunteers are compensated and the amount varies depending on the length of the clinical trial, length of stay and number of follow-up visits. The compensation is not specifically related to the risks or type of drug involved in the trials or studies. Every study is different and therefore, the compensation will vary. Study volunteers may receive between $1000 to $4000 for a trial (based on the factors listed above).

Are food and accommodation provided over the course of the trial?

Food – Clinical trials are conducted in a controlled setting which means that all food is provided and  trial volunteers receive standardised meals.  Individual meal plans or meal preferences cannot be provided.  If you have any food allergies or hypersensitivity to food product(s) that are clinically significant or life-threatening you may not be able to participate in a trial.    Please contact us to discuss any food issues.

Accommodation – During your in-clinic stay you will share sleeping areas with other volunteers who are of the same gender.  Similar to a hospital setting, supervision will be provided to ensure that your health and safety are being monitored.

What is the length of a study and do I have to complete all the visits?

Details of the duration of a study can be found on the Volunteer Hub.

What is informed consent and how is it carried out?

Before you decide whether or not to take part in a clinical research study, you will be required to read and understand the information provided in an Informed Consent Form (ICF).  The ICF describes the clinical research study and the nature of the investigational product to be used, including:

  • Your rights and responsibilities as a study participant.
  • What you will be asked to do during study participation.
  • The potential risks that you should be aware of.

During this process, you will have the opportunity to discuss and ask questions related to the conduct of the clinical research study with the study doctor/ study staff.  You are under no obligation to participate and your decision to take part in a clinical trial is voluntary.

Can I bring my own food?

All aspects of clinical trials are closely monitored including the food and drink consumed by participants. While you are in the clinic, you will be provided with all meals as per the study guidelines. You will need to eat all the food provided to ensure the guidelines are met.

When do I receive compensation for taking part in a study?

You will receive compensation as outlined during the Informed Consent process. Typically, you will receive compensation once all study visits have been completed. If, for any reason, you do not complete all study visits, your compensation will be on a pro-rated basis (i.e. for the time that you have participated in the trial)

What COVID-19 precautions are you taking?

The safety of our volunteers is a top priority. Learn more about the measures we are taking to create a safe environment for you.

Can I bring my own device?

Yes, we encourage you to bring items that will help to pass the time while you are in the clinic. You can use the time to study or work or catch up on the movies you’ve been meaning to watch.

Privacy

We respect and value the privacy of our volunteers. View our Privacy and Cookie Policy here.

Schedule a Discovery
Call Today

Complete the form to schedule a Discovery Call with one of our medical experts to learn how BioPharma Services can be your trusted clinical trial partner.

[]
1 Step 1

Nameyour full name
Phone
Company
Your Inquiry
0 /
reCaptcha v3
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder